For small molecule pharma and biotech companies looking for “one stop” sterile injectable fill/finish capabilities for clinical phase or commercial projects, August Bio has the operational flexibility and available capacity to support small-, mid-size, and large-scale batches today and as client volumes grow. Recent facility renovation has added multiple state-of-the-art filling lines (for bottles/vials, PFS/cartridges and IV bags), as well as terminal sterilization and lyophilization technologies, while ongoing expansion activities are adding another high-speed vial line, another high-speed PFS line, and a unique capability not often found at CDMOs – an aseptic IV bag filling line. For available capacity at the right scale at the right time, choose August Bio.
Key Learning Objectives:
- Hear from an industry expert that knows both the science and the business sides of the CDMO selection process
- Learn how August Bio’s multi-line expansion (vials, bottles, PFS, cartridges and IV bags) offers exceptional fill/finish flexibility to provide the right scale at the right time
- Understand the advantages of a CDMO with robust formulation development, analytical services and cGMP manufacturing all on a single site